Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Insulin Pump Settings During Breastfeeding in Women with Type 1 Diabetes.

Nørgaard SK, Nørgaard K, Roskjær AB, Mathiesen ER, Ringholm L.

Diabetes Technol Ther. 2019 Oct 22. doi: 10.1089/dia.2019.0280. [Epub ahead of print]

PMID:
31580150
2.

Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor Site.

Laugesen C, Schmidt S, Tetzschner R, Nørgaard K, Ranjan A.

Diabetes Technol Ther. 2019 Sep 27. doi: 10.1089/dia.2019.0278. [Epub ahead of print]

PMID:
31560217
3.

Preference for Subcutaneously Administered Low-Dose Glucagon Versus Orally Administered Glucose for Treatment of Mild Hypoglycemia: A Prospective Survey Study.

Tetzschner R, Ranjan AG, Schmidt S, Nørgaard K.

Diabetes Ther. 2019 Sep 24. doi: 10.1007/s13300-019-00696-x. [Epub ahead of print]

PMID:
31552599
4.

On the calculation of reflectance in non-uniform ear canals.

Nørgaard KR, Charaziak KK, Shera CA.

J Acoust Soc Am. 2019 Aug;146(2):1464. doi: 10.1121/1.5124000.

PMID:
31472574
5.

A comparison of ear-canal-reflectance measurement methods in an ear simulator.

Nørgaard KR, Charaziak KK, Shera CA.

J Acoust Soc Am. 2019 Aug;146(2):1350. doi: 10.1121/1.5123379.

PMID:
31472530
6.

Psychogenic nonepileptic seizures treated with psychotherapy: Long-term outcome on seizures and healthcare utilization.

Deleuran M, Nørgaard K, Andersen NB, Sabers A.

Epilepsy Behav. 2019 Sep;98(Pt A):195-200. doi: 10.1016/j.yebeh.2019.05.007. Epub 2019 Aug 1.

PMID:
31377661
7.

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.

Agesen RM, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen T, Juhl CB, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U.

BMC Endocr Disord. 2019 Jul 23;19(1):78. doi: 10.1186/s12902-019-0408-x.

8.

Compensating for oblique ear-probe insertions in ear-canal reflectance measurements.

Nørgaard KR, Fernandez-Grande E, Laugesen S.

J Acoust Soc Am. 2019 Jun;145(6):3499. doi: 10.1121/1.5111340.

PMID:
31255109
9.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

10.

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice.

Evans M, Ceriello A, Danne T, De Block C, DeVries JH, Lind M, Mathieu C, Nørgaard K, Renard E, Wilmot EG.

Diabetes Obes Metab. 2019 Sep;21(9):2039-2047. doi: 10.1111/dom.13798. Epub 2019 Jun 19. Review.

11.

Loss of mismatch repair signaling impairs the WNT-bone morphogenetic protein crosstalk and the colonic homeostasis.

Nørgaard K, Müller C, Christensen N, Chiloeches ML, Madsen CL, Nielsen SS, Thingholm TE, Belcheva A.

J Mol Cell Biol. 2019 May 8. pii: mjz031. doi: 10.1093/jmcb/mjz031. [Epub ahead of print]

PMID:
31065691
12.

A Response to "The Relationship Between Sleep and Quality of Life in Type 1 Diabetes Patients".

Nørgaard K, Kielgast U.

Diabetes Ther. 2019 Jun;10(3):1173-1174. doi: 10.1007/s13300-019-0622-6. Epub 2019 Apr 26. No abstract available.

13.

Comparison of Continuous Glucose Monitoring Accuracy Between Abdominal and Upper Arm Insertion Sites.

Steineck IIK, Mahmoudi Z, Ranjan A, Schmidt S, Jørgensen JB, Nørgaard K.

Diabetes Technol Ther. 2019 May;21(5):295-302. doi: 10.1089/dia.2019.0014. Epub 2019 Apr 17.

PMID:
30994362
14.

Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.

Christensen MO, Berg AK, Rytter K, Hommel E, Thyssen JP, Svensson J, Nørgaard K.

Diabetes Technol Ther. 2019 Apr;21(4):215-221. doi: 10.1089/dia.2019.0007.

PMID:
30943072
15.

Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study.

Schmidt S, Christensen MB, Serifovski N, Damm-Frydenberg C, Jensen JB, Fløyel T, Størling J, Ranjan A, Nørgaard K.

Diabetes Obes Metab. 2019 Jul;21(7):1680-1688. doi: 10.1111/dom.13725. Epub 2019 Apr 21.

PMID:
30924570
16.

Optimizing large-scale ageing of municipal solid waste incinerator bottom ash prior to the advanced metal recovery: Phase I: Monitoring of temperature, moisture content, and CO2 level.

Nørgaard KP, Hyks J, Mulvad JK, Frederiksen JO, Hjelmar O.

Waste Manag. 2019 Feb 15;85:95-105. doi: 10.1016/j.wasman.2018.12.019. Epub 2018 Dec 20.

PMID:
30803619
17.

Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.

Christensen MB, Gæde P, Hommel E, Gotfredsen A, Nørgaard K.

Diabetes Metab. 2019 Feb 21. pii: S1262-3636(19)30029-1. doi: 10.1016/j.diabet.2019.02.002. [Epub ahead of print]

PMID:
30796973
18.

Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey.

Nørgaard K, Kielgast U.

Diabetes Ther. 2019 Apr;10(2):635-647. doi: 10.1007/s13300-019-0587-5. Epub 2019 Feb 19.

19.

Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.

Steineck IIK, Ranjan A, Schmidt S, Clausen TR, Holst JJ, Nørgaard K.

Diabetologia. 2019 Apr;62(4):582-592. doi: 10.1007/s00125-018-4807-8. Epub 2019 Jan 14.

PMID:
30643924
20.

Evanescent waves in simulated ear canals: Experimental demonstration and method for compensation.

Siegel JH, Nørgaard KR, Neely ST.

J Acoust Soc Am. 2018 Oct;144(4):2135. doi: 10.1121/1.5058683.

21.

A coupler-based calibration method for ear-probe microphones.

Nørgaard KR, Fernandez-Grande E, Laugesen S.

J Acoust Soc Am. 2018 Oct;144(4):2294. doi: 10.1121/1.5064283.

PMID:
30404519
22.

In-Place Modulation of Rectification in Tunneling Junctions Comprising Self-Assembled Monolayers.

Ai Y, Kovalchuk A, Qiu X, Zhang Y, Kumar S, Wang X, Kühnel M, Nørgaard K, Chiechi RC.

Nano Lett. 2018 Dec 12;18(12):7552-7559. doi: 10.1021/acs.nanolett.8b03042. Epub 2018 Nov 9.

23.

Who Needs Neighbors? PKS8 Is a Stand-Alone Gene in Fusarium graminearum Responsible for Production of Gibepyrones and Prolipyrone B.

Westphal KR, Muurmann AT, Paulsen IE, Nørgaard KTH, Overgaard ML, Dall SM, Aalborg T, Wimmer R, Sørensen JL, Sondergaard TE.

Molecules. 2018 Sep 2;23(9). pii: E2232. doi: 10.3390/molecules23092232.

24.

Dry Chemistry of Ferrate(VI): A Solvent-Free Mechanochemical Way for Versatile Green Oxidation.

Zhang ZY, Ji D, Mao W, Cui Y, Wang Q, Han L, Zhong H, Wei Z, Zhao Y, Nørgaard K, Li T.

Angew Chem Int Ed Engl. 2018 Aug 20;57(34):10949-10953. doi: 10.1002/anie.201805998. Epub 2018 Jul 20.

PMID:
29952136
25.

Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.

Berg AK, Nørgaard K, Thyssen JP, Zachariae C, Hommel E, Rytter K, Svensson J.

Diabetes Technol Ther. 2018 Jul;20(7):475-482. doi: 10.1089/dia.2018.0088. Epub 2018 Jun 12.

PMID:
29893593
26.

Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study.

Reiterer F, Reiter M, Del Re L, Bechmann Christensen M, Nørgaard K.

J Diabetes Sci Technol. 2018 Sep;12(5):1029-1040. doi: 10.1177/1932296818770694. Epub 2018 Apr 21.

27.

Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.

Nørgaard K, Sukumar N, Rafnsson SB, Saravanan P.

Diabetes Ther. 2018 Jun;9(3):891-917. doi: 10.1007/s13300-018-0411-7. Epub 2018 Apr 5. Review.

28.

Quantifying undesired parallel components in Thévenin-equivalent acoustic source parameters.

Nørgaard KR, Neely ST, Rasetshwane DM.

J Acoust Soc Am. 2018 Mar;143(3):1491. doi: 10.1121/1.5026796.

29.

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.

Agesen RM, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Jensen T, Parving HH, Thorsteinsson B, Tarnow L, Pedersen-Bjergaard U.

Diabetes Technol Ther. 2018 Mar;20(3):247-256. doi: 10.1089/dia.2017.0372. Epub 2018 Mar 12.

PMID:
29565719
30.

Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.

Ranjan A, Nørgaard K, Tetzschner R, Steineck IIK, Clausen TR, Holst JJ, Madsbad S, Schmidt S.

Diabetes Care. 2018 Apr;41(4):797-806. doi: 10.2337/dc17-1458. Epub 2018 Jan 22.

PMID:
29358493
31.

Compensating for evanescent modes and estimating characteristic impedance in waveguide acoustic impedance measurements.

Nørgaard KR, Fernandez-Grande E, Laugesen S.

J Acoust Soc Am. 2017 Dec;142(6):3497. doi: 10.1121/1.5016808.

PMID:
29289093
32.

Incorporating evanescent modes and flow losses into reference impedances in acoustic Thévenin calibration.

Nørgaard KR, Fernandez-Grande E, Laugesen S.

J Acoust Soc Am. 2017 Nov;142(5):3013. doi: 10.1121/1.5010891.

PMID:
29195468
33.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

34.

The effect of peer support in adults with insulin pump-treated type 1 diabetes: a pilot study of a flexible and participatory intervention.

Joensen LE, Meldgaard Andersen M, Jensen S, Nørgaard K, Willaing I.

Patient Prefer Adherence. 2017 Nov 2;11:1879-1890. doi: 10.2147/PPA.S142204. eCollection 2017.

35.

Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-A systematic review with GRADE.

Tetzschner R, Nørgaard K, Ranjan A.

Diabetes Metab Res Rev. 2018 Mar;34(3). doi: 10.1002/dmrr.2965. Epub 2018 Jan 29. Review.

PMID:
29135074
36.

Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.

Ranjan A, Wendt SL, Schmidt S, Madsbad S, Holst JJ, Madsen H, Knudsen CB, Jørgensen JB, Nørgaard K.

Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):322-330. doi: 10.1111/bcpt.12907. Epub 2017 Oct 11.

37.

Evaluation of pharmacokinetic model designs for subcutaneous infusion of insulin aspart.

Mansell EJ, Schmidt S, Docherty PD, Nørgaard K, Jørgensen JB, Madsen H.

J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):477-489. doi: 10.1007/s10928-017-9535-z. Epub 2017 Aug 22.

PMID:
28831695
38.

Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.

Wendt SL, Ranjan A, Møller JK, Schmidt S, Knudsen CB, Holst JJ, Madsbad S, Madsen H, Nørgaard K, Jørgensen JB.

J Diabetes Sci Technol. 2017 Nov;11(6):1101-1111. doi: 10.1177/1932296817693254. Epub 2017 Feb 1.

39.

Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate counting.

Schmidt S, Vistisen D, Almdal T, Hommel E, Nørgaard K.

Diabetes Res Clin Pract. 2017 Aug;130:61-66. doi: 10.1016/j.diabres.2017.05.021. Epub 2017 May 19.

PMID:
28570925
40.

Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial.

Ranjan A, Schmidt S, Damm-Frydenberg C, Holst JJ, Madsbad S, Nørgaard K.

Diabetes Obes Metab. 2017 Oct;19(10):1479-1484. doi: 10.1111/dom.12953. Epub 2017 Jul 10.

PMID:
28345762
41.

Comparison of three nonlinear filters for fault detection in continuous glucose monitors.

Mahmoudi Z, Wendt SL, Boiroux D, Hagdrup M, Norgaard K, Poulsen NK, Madsen H, Jorgensen JB.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3507-3510. doi: 10.1109/EMBC.2016.7591484.

PMID:
28269054
42.

Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.

Steineck I, Ranjan A, Nørgaard K, Schmidt S.

J Diabetes Sci Technol. 2017 Jan;11(1):50-58. doi: 10.1177/1932296816672689. Epub 2016 Oct 6. Review.

43.

Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.

Kristensen PL, Tarnow L, Bay C, Nørgaard K, Jensen T, Parving HH, Perrild H, Beck-Nielsen H, Christiansen JS, Thorsteinsson B, Pedersen-Bjergaard U.

Diabet Med. 2017 May;34(5):625-631. doi: 10.1111/dme.13317. Epub 2017 Feb 14.

PMID:
28099755
44.

Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers.

Renault KM, Carlsen EM, Hædersdal S, Nilas L, Secher NJ, Eugen-Olsen J, Cortes D, Olsen SF, Halldorsson TI, Nørgaard K.

Int J Obes (Lond). 2017 Apr;41(4):598-605. doi: 10.1038/ijo.2017.9. Epub 2017 Jan 17.

PMID:
28093573
45.

Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.

Christensen MB, Gotfredsen A, Nørgaard K.

Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2885. Epub 2017 Feb 23. Review.

PMID:
28067472
46.

The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial.

Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Parving HH, Thorsteinsson B, Tarnow L.

Diabetes Res Clin Pract. 2017 Jan;123:143-148. doi: 10.1016/j.diabres.2016.11.003. Epub 2016 Nov 16.

PMID:
28012403
47.

[The field of technologies for diabetes treatment].

Nørgaard K, Schmidt S.

Ugeskr Laeger. 2016 Dec 12;178(50). pii: V08160552. Review. Danish.

PMID:
27966423
48.

Aquaporins in the Spinal Cord.

Oklinski MK, Skowronski MT, Skowronska A, Rützler M, Nørgaard K, Nieland JD, Kwon TH, Nielsen S.

Int J Mol Sci. 2016 Dec 7;17(12). pii: E2050. Review.

49.

Determining lower threshold concentrations for synergistic effects.

Bjergager MA, Dalhoff K, Kretschmann A, Nørgaard KB, Mayer P, Cedergreen N.

Aquat Toxicol. 2017 Jan;182:79-90. doi: 10.1016/j.aquatox.2016.10.020. Epub 2016 Oct 24.

PMID:
27875797
50.

Long-Term Adherence to Automated Bolus Calculators.

Schmidt S, Nørgaard K, Neergaard K, Almdal T, Hommel EE.

J Diabetes Sci Technol. 2017 Jan;11(1):174-175. doi: 10.1177/1932296816672692. Epub 2016 Nov 2. No abstract available.

Supplemental Content

Loading ...
Support Center